Bioresorbable Vascular Scaffold Is as Safe as Metal Stent, A New Study Confirms

Published Date: Feb 2016

Researchers at ABSORB Japan found that patients undergoing percutaneous coronary intervention (PCI) showed similar results using drug-eluting coronary stent or ‘scaffolds’ produced from bioresorbable material as compared to using metal stent. A study conducted by ABSORB included 400 participants of an average age 67.2 years. 266 of patients out of 400 underwent PCI using bioresorbable stent and remaining through metal stents. Both of the types were coated with Everolimus to prevent re-blockage of the artery.

Metal stent is a material used in production of vascular stents. It is primarily used for cardiovascular diseases and vessel related blockages. Target lesion failure was the primary endpoint of the study at one year. It occurred in 4.2% of the patients with bioresorbable vascular scaffolds (BVS) and 3.8% of the patients with metal stents indicating non-inferiority of BVS. The second endpoint was at 13 months, which was angiographic in-segment late lumen loss (LLL). Again, the results showed non-inferiority of BVS. The study was conducted to support regulatory approval for BVS in Japan.

Dr. Takeshi Kimura, PhD, from Kyoto University Hospital, Kyoto, Japan said, "These results support the feasibility of BVS to potentially improve the long-term outcomes of patients, BVS demonstrated a similar 12-month clinical safety and efficacy profile as the metal stent, with comparable 13-month angiographic outcomes. These results are consistent with a few previous studies reporting either 12-month clinical outcome or 9-month angiographic outcome, supporting the feasibility of BVS use to potentially improve the long-term outcomes of patients undergoing PCI."

Many reports have been published analyzing the changing market status of diabetes devices industry. Recently, Prof Research Reports has added a report titled “2015 Vascular Stent Industry Report - Global and Chinese Market Scenario.” The report offers an extensive analysis of production information, key manufacturers, industry chain structure, and investment feasibility studies of the global vascular stent industry with a spotlight on Chinese market. 

Share This News
facebooktwitterlinkedingoogleplusstumbleuponreddit
24/7 Customer Support
check Have questions?
Direct
+1-971-202-1575
Toll Free
+1(855)711-1555 or2
email help@profresearchreports.com
Market Research

Prof Research Report is a high end market research & consulting firm that offers current and future market intelligence across 30 industrial verticals such as energy, new materials, transportation, daily consumer goods, chemicals, etc through is quality database. Prof Research Report has successfully utilized technology to manage complex and massive market related database, which offers research reports of high analytical value. Prof Research Report’s aim is to help our clients in achieving sustainable growth by providing insightful and qualitative research reports. Our research reports help our clients to achieve the competitive edge in the market.

Vision:

To be a world class provider of market research reports.

Mission:

To create a database of reliable and accurately analyzed report and be the decision making support for our clients.

CONTACT 5320 SW MACADAM AVENUE, SUITE 100, PORTLAND, OR 97239, UNITED STATES. © 2016. ALL RIGHTS RESERVED PROF RESEARCH REPORTS.